Diagnosis and Symptoms of Iron Overload
The diagnosis of iron overload should begin with serum transferrin saturation (>45%) and serum ferritin (>200 μg/L in women or >300 μg/L in men) measurements, followed by genetic testing for HFE mutations in suspected cases of hereditary hemochromatosis. 1
Diagnostic Approach
Laboratory Testing
Initial screening tests:
Confirmatory genetic testing:
- Test for HFE gene mutations (C282Y and H63D) when iron overload is suspected 1
- C282Y homozygosity or C282Y/H63D compound heterozygosity confirms hereditary hemochromatosis
Additional laboratory assessment:
- Liver function tests (elevated transaminases may indicate liver damage)
- Ferritin/AST ratio can help predict tissue iron overload with high sensitivity (83.3%) and specificity (78.6%) 2
Imaging Studies
- MRI with quantitative iron assessment: Non-invasive method to quantify iron deposition in liver and heart 1
- Echocardiography: May show biventricular dilatation and restrictive cardiomyopathy in cardiac iron overload 1
- Tissue Doppler imaging: Can detect early diastolic dysfunction before systolic dysfunction occurs 1
Tissue Biopsy
- Liver biopsy: Gold standard for diagnosing liver iron overload 1
- Perls' Prussian blue stain assesses iron distribution
- Quantitative iron measurement by atomic absorption spectrometry
- Myocardial biopsy: Less reliable due to patchy iron deposition in the heart 1
Clinical Symptoms and Signs
Asymptomatic Presentation
- Many patients are identified through abnormal iron studies on routine screening or family screening 1
- Patients should be evaluated for hemochromatosis even in the absence of symptoms if iron studies are abnormal 1
Systemic Symptoms
- Weakness and lethargy: Present in 19-83% of patients 1
- Fatigue: Common early symptom
- Weight loss
- Apathy
Organ-Specific Symptoms
Liver manifestations:
Joint manifestations:
- Arthralgias (13-57% of patients) 1
- Arthritis, particularly in metacarpophalangeal joints
Endocrine manifestations:
Cardiac manifestations:
Skin manifestations:
Important Clinical Considerations
- Serum ferritin >1,000 ng/mL is associated with increased risk of hepatic fibrosis or cirrhosis 1
- Ferritin can be elevated in inflammatory conditions without true iron overload, as it's an acute phase reactant 1
- Cardiac iron deposition may occur despite normal serum ferritin levels 1
- All patients with evidence of liver disease should be evaluated for hemochromatosis 1
Diagnostic Pitfalls to Avoid
Relying solely on ferritin levels: Ferritin can be elevated in inflammation, infection, malignancy, and liver disease without true iron overload 1
Missing hereditary hemochromatosis in patients with mild symptoms: Many patients present with nonspecific symptoms that can be overlooked
Failing to screen family members: First-degree relatives of patients with hereditary hemochromatosis should be screened 1
Overlooking secondary causes of iron overload: Consider hematologic disorders (thalassemia, myelodysplastic syndrome), chronic transfusions, and chronic liver diseases 3
Delaying diagnosis until end-organ damage occurs: Cardiac involvement often develops late in the disease process when treatment may be less effective 1
Early diagnosis and treatment of iron overload are essential to prevent irreversible organ damage and improve mortality and quality of life outcomes.